|
|||||
|
|
The effect of inspiratory parameters after two separate inhalations on the dose emission of theophylline from low and high resistance dry powder inhalers |
|
| Institution: | 1. Department of Pharmacy and Pharmaceutical Sciences, University of Huddersfield, Huddersfield HD1 3DH, United Kingdom;2. Department of Pharmacy and Pharmaceutical Sciences, University of Tobruk, Libya |
| Abstract: | The dose emission from DPIs can be affected by the inspiratory parameters achieved by the patient as well as the device in-use. Conventional in-vitro dose emission methodology was used, but instead of using inhalation volume (Vin) of 2 or 4 L and peak inhalation flow (PIF) corresponding to 4 kPa, a range of PIFs (28.3, 60, 90 and 120 L min?1) and Vins (0.5, 0.75, 1, 1.5, 2, and 4 L) were used. The formulation was composed of spray dried Theophylline as a model drug with Lactohale® α lactose monohydrate carrier. The formulation was aerosolised using two DPIs; a low resistance Breezhaler® and high resistance Handihaler®. The formulation showed a consistent dose content uniformity with a Coefficient of Variation (CV) of 1.70%. The drug distribution on the surface of the carrier was obvious from the SE micrographs with some drug particles lodged into lactose crevices. The dose emission after the first inhalation (ED1) and total emitted dose (TED) of theophylline increased with PIF and Vin, irrespective of the inhaler device. However, the dose delivered was superior for the Handihaler® compared to Breezhaler®. Drug retention in the capsule and device was high at low PIFs and Vins and reduced after the second inhalation. Therefore, our study supports the recommendations for patients who cannot achieve sufficient PIF and Vin to inhale twice for each dose to ensure the better clinical outcome. |
| Keywords: | Peak inhalation flow Inhalation volume Theophylline Handihaler® Onbrez Breezhaler® DPIs"} {"#name":"keyword" "$":{"id":"k0035"} "$$":[{"#name":"text" "_":"Dry powder inhalers ED"} {"#name":"keyword" "$":{"id":"k0045"} "$$":[{"#name":"text" "_":"Emitted dose ED1"} {"#name":"keyword" "$":{"id":"k0055"} "$$":[{"#name":"text" "_":"Dose emitted after first inhalation ED2"} {"#name":"keyword" "$":{"id":"k0065"} "$$":[{"#name":"text" "_":"Dose emitted after second inhalation DUSA"} {"#name":"keyword" "$":{"id":"k0075"} "$$":[{"#name":"text" "_":"Dose unit sampling apparatus TED"} {"#name":"keyword" "$":{"id":"k0085"} "$$":[{"#name":"text" "_":"Total Emitted Dose TRD"} {"#name":"keyword" "$":{"id":"k0095"} "$$":[{"#name":"text" "_":"Total recovered dose TRA"} {"#name":"keyword" "$":{"id":"k0105"} "$$":[{"#name":"text" "_":"Total residual amount PIF"} {"#name":"keyword" "$":{"id":"k0115"} "$$":[{"#name":"text" "_":"Peak inhalation flow Vin"} {"#name":"keyword" "$":{"id":"k0125"} "$$":[{"#name":"text" "_":"inhalation volume PIL"} {"#name":"keyword" "$":{"id":"k0135"} "$$":[{"#name":"text" "_":"Patient information leaflets TRA"} {"#name":"keyword" "$":{"id":"k0145"} "$$":[{"#name":"text" "_":"Total Residual amount SEM"} {"#name":"keyword" "$":{"id":"k0155"} "$$":[{"#name":"text" "_":"Scanning electron microscope API"} {"#name":"keyword" "$":{"id":"k0165"} "$$":[{"#name":"text" "_":"Active pharmaceutical ingredient |
| 本文献已被 ScienceDirect 等数据库收录！ | |